Life Science Paradigm Challenge

Cancer can trick the body into growing new blood vessels not by starving for oxygen, but by breathing harder than a healthy cell ever could.

April 15, 2026

Original Paper

Protein import-driven mitochondrial hyperactivation dictates angiogenesis independently of HIF-1α

Chaudhary, T.; Bhat, S. M.; Pradhan, P.; Joshi, M. B.; Sinha, D.

bioRxiv · 10.64898/2026.04.11.717880

The Takeaway

For decades, we’ve assumed that tumors only trigger the growth of new blood vessels when they are suffocating and desperate for oxygen. This paper flips that entire model on its head by showing that tumors can actually bypass that 'starvation' signal entirely. Instead, they use a process called mitochondrial hyperactivation to put their internal energy factories into a literal turbo mode. By flooding themselves with specific proteins, these mitochondria go into overdrive and release chemical signals that force the body to build them a private plumbing system, even when oxygen levels are perfectly fine. This is a massive deal for medicine because it explains why many current cancer drugs—which only target the starvation pathway—often fail to stop a tumor from spreading. It means we might need to start focusing on slowing down the tumor's engine rather than just trying to cut off its air supply.

From the abstract

Angiogenesis is essential for sustained neoplastic progression, yet its initiation has largely been framed through hypoxia-dependent HIF signalling. In OXPHOS driven tumours, how mitochondrial function contributes to angiogenic induction remains poorly understood. Here, we uncover a non-canonical mechanism linking tumour cell mitochondrial hyperactivity to a pro-angiogenic response. Mitochondrial function critically depends on the import of nuclear-encoded proteins, largely mediated by TIM23 tra